Klinická odpověď těžké mechanobulózní epidermolysis bullosa acquista na kombinovanou léčbu imunoadsorpcí a rituximabem (A. Niedermeier - R. Eming - M. Pfütze et al.: Clinical response severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab, an anti-CD 20 monoclonal antibody)